Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herman Waldmann

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
JCI Insight|February 15, 2017
Foxp3 drives oxidative phosphorylation and protection from lipotoxicityDuncan Howie, Stephen Paul Cobbold, Elizabeth Adams, et al.
Plos One|August 26, 2016
CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab TreatmentRyuichi Hotta, Masahiro Ohira, Toshiharu Matsuura, et al.
Cell Reports|August 9, 2018
Regulatory T Cells Promote Apelin-Mediated Sprouting Angiogenesis in Type 2 DiabetesOscar M Leung, Jiatao Li, Xisheng Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 4, 2010
A novel strategy to reduce the immunogenicity of biological therapiesJennifer Somerfield, Grant A Hill-Cawthorne, Andrew Lin, et al.
Frontiers in Immunology|March 12, 2015
Dickkopf-3, a tissue-derived modulator of local T-cell responsesMichael Meister, Maria Papatriantafyllou, Viola Nordström, et al.
Journal of Virology|September 15, 2005
CD8+ lymphocytes do not mediate protection against acute superinfection 20 days after vaccination with a live attenuated simian immunodeficiency virusRichard Stebbings, Neil Berry, Herman Waldmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 19, 2012
Foxp3 expression is required for the induction of therapeutic tissue toleranceFrederico S Regateiro, Ye Chen, Adrian R Kendal, et al.
Lancet (London, England)|June 7, 2005
Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantationKarl S Peggs, Ann Hunter, Rajesh Chopra, et al.
Blood|December 17, 2009
Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patientsBart Keymeulen, Sophie Candon, Samira Fafi-Kremer, et al.
Blood|May 31, 2002
High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitutionSuparno Chakrabarti, Stephen Mackinnon, Raj Chopra, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
JCI Insight|February 15, 2017
Foxp3 drives oxidative phosphorylation and protection from lipotoxicityDuncan Howie, Stephen Paul Cobbold, Elizabeth Adams, et al.
Plos One|August 26, 2016
CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab TreatmentRyuichi Hotta, Masahiro Ohira, Toshiharu Matsuura, et al.
Cell Reports|August 9, 2018
Regulatory T Cells Promote Apelin-Mediated Sprouting Angiogenesis in Type 2 DiabetesOscar M Leung, Jiatao Li, Xisheng Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 4, 2010
A novel strategy to reduce the immunogenicity of biological therapiesJennifer Somerfield, Grant A Hill-Cawthorne, Andrew Lin, et al.
Frontiers in Immunology|March 12, 2015
Dickkopf-3, a tissue-derived modulator of local T-cell responsesMichael Meister, Maria Papatriantafyllou, Viola Nordström, et al.
Journal of Virology|September 15, 2005
CD8+ lymphocytes do not mediate protection against acute superinfection 20 days after vaccination with a live attenuated simian immunodeficiency virusRichard Stebbings, Neil Berry, Herman Waldmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 19, 2012
Foxp3 expression is required for the induction of therapeutic tissue toleranceFrederico S Regateiro, Ye Chen, Adrian R Kendal, et al.
Lancet (London, England)|June 7, 2005
Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantationKarl S Peggs, Ann Hunter, Rajesh Chopra, et al.
Blood|December 17, 2009
Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patientsBart Keymeulen, Sophie Candon, Samira Fafi-Kremer, et al.
Blood|May 31, 2002
High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitutionSuparno Chakrabarti, Stephen Mackinnon, Raj Chopra, et al.
Pageof 16